On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Tomohiro Fujiwara

ResearcherPublications, citations & collaboration network

Tomohiro Fujiwara is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Tomohiro Fujiwara have?

ScholarIQindexed works

Tomohiro Fujiwara has 236 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Tomohiro Fujiwara have?

ScholarIQcitation count

Tomohiro Fujiwara has 3,734 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Tomohiro Fujiwara?

ScholarIQh-index

Tomohiro Fujiwara has an h-index of 34 in OpenAlex.

What is the i10-index of Tomohiro Fujiwara?

ScholarIQi10-index

Tomohiro Fujiwara has an i10-index of 89 in OpenAlex.

What is the ORCID of Tomohiro Fujiwara?

ScholarIQorcid

The ORCID for Tomohiro Fujiwara is on the source record.

What is the OpenAlex record for Tomohiro Fujiwara?

ScholarIQopenalex

The OpenAlex for Tomohiro Fujiwara is on the source record.

What are the most-cited papers on Tomohiro Fujiwara?

ScholarIQmost cited works
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
Tomohiro Fujiwara, Mohamed A. Yakoub, Andrew Chandler, Alexander B. Christ, Guangli Yang, Ouathek Ouerfelli, Vinagolu K. Rajasekhar, Aki Yoshida, Hiroya Kondo, Toshiaki Hata, Hiroshi Tazawa, Yildirim Dogan, Malcolm A.S. Moore, Toshiyoshi Fujiwara, Toshifumi Ozaki, Ed Purdue, John H. Healey
Molecular Cancer Therapeutics. 2021269 CitationsOPEN ACCESS
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
Yu Fujita, Shigehiro Yagishita, Keitaro Hagiwara, Yusuke Yoshioka, Nobuyoshi Kosaka, Fumitaka Takeshita, Tomohiro Fujiwara, Koji Tsuta, Hiroshi Nokihara, Tomohide Tamura, Hisao Asamura, Makoto Kawaishi, Kazuyoshi Kuwano, Takahiro Ochiya
Molecular Therapy. 2015265 CitationsOPEN ACCESS
Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma
Tomohiro Fujiwara, Koji Uotani, Aki Yoshida, Takuya Morita, Yutaka Nezu, Eisuke Kobayashi, Akihiko Yoshida, Takenori Uehara, Toshinori Omori, Kazuhisa Sugiu, Tadashi Komatsubara, Ken Takeda, Toshiyuki Kunisada, Machiko Kawamura, Akira Kawai, Takahiro Ochiya, Toshifumi Ozaki
Oncotarget. 2017119 CitationsOPEN ACCESS
Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects
Takenori Uehara, Shingo Eikawa, Mikako Nishida, Yuki Kunisada, Aki Yoshida, Tomohiro Fujiwara, Toshiyuki Kunisada, Toshifumi Ozaki, Heiichiro Udono
International Immunology. 2018118 CitationsOPEN ACCESS
Unique mutation portraits and frequent <i>COL2A1</i> gene alteration in chondrosarcoma
Yasushi Totoki, Akihiko Yoshida, Fumie Hosoda, Hiromi Nakamura, Natsuko Hama, Koichi Ogura, Aki Yoshida, Tomohiro Fujiwara, Yasuhito Arai, Junya Toguchida, Hitoshi Tsuda, Satoru Miyano, Akira Kawai, Tatsuhiro Shibata
Genome Research. 2014100 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial